Alexis Borisy


Alexis Borisy is a leading biotechnology entrepreneur and investor with more than 25 years of experience and Executive Chairman and former CEO of EQRx. He founded CombinatoRx in 1999 and is the co-founder of Foundation Medicine, Blueprint Medicines, Celsius Therapeutics and Relay Therapeutics. He's also a founding investor for Editas Medicine, Magenta Therapeutics, Revolution Medicines and Thrive Earlier Detection. Alexis is the Vice Chairman of the Board of Trustees of the Boston Museum of Science. He holds a master's degree in chemistry and chemical biology from Harvard University and a B.S. i

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved